D-dimer, BNP/NT-pro-BNP, and creatinine are reliable decision-making biomarkers in life-sustaining therapies withholding and withdrawing during COVID-19 outbreak

BACKGROUND: The decision for withholding and withdrawing of life-sustaining treatments (LSTs) in COVID-19 patients is currently based on a collegial and mainly clinical assessment. In the context of a global pandemic and overwhelmed health system, the question of LST decision support for COVID-19 pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Smadja, David M., Fellous, Benjamin A., Bonnet, Guillaume, Hauw-Berlemont, Caroline, Sutter, Willy, Beauvais, Agathe, Fauvel, Charles, Philippe, Aurélien, Weizman, Orianne, Mika, Delphine, Juvin, Philippe, Waldmann, Victor, Diehl, Jean-Luc, Cohen, Ariel, Chocron, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485619/
https://www.ncbi.nlm.nih.gov/pubmed/36148049
http://dx.doi.org/10.3389/fcvm.2022.935333

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485619/
https://www.ncbi.nlm.nih.gov/pubmed/36148049
http://dx.doi.org/10.3389/fcvm.2022.935333

Ejemplares similares